Author

Sarah Svenja Dinges

Observed names: Dinges, Sarah Svenja, S Dinges, Sarah Dinges, Sarah S. Dinges

Institutions: National Institutes of Health, Humboldt-Universität zu Berlin, Berlin-Brandenburger Centrum für Regenerative Therapien, National Institute of Allergy and Infectious Diseases, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Stiftung Charité, Freie Universität Berlin, Charité - Universitätsmedizin Berlin

Observed institutions: National Institutes of Health, Harvard University, Humboldt-Universität zu Berlin, Massachusetts General Hospital, Berlin-Brandenburger Centrum für Regenerative Therapien, National Institute of Allergy and Infectious Diseases, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Stiftung Charité, Freie Universität Berlin, Charité - Universitätsmedizin Berlin

ORCID: 0000-0002-8134-7350

Observed ORCID: 0000-0002-8134-7350

OpenAlex ID: A5038959564

Cancer metabolomic markers in urine: evidence, techniques and recommendations

2019 · Sarah S. Dinges, Annika Hohm, et al. · Nature Reviews Urology · 161

Inborn errors of immunity: Manifestation, treatment, and outcome—an ESID registry 1994–2024 report on 30,628 patients

2025 · Gerhard Kindle, Mickaël Alligon, et al. · Journal of Human Immunity · 46

PDF

Primary and secondary defects of the thymus

2024 · Sarah S. Dinges, Kayla Amini, et al. · Immunological Reviews · 31

PDF

Magnetic Resonance Spectroscopy-based Metabolomic Biomarkers for Typing, Staging, and Survival Estimation of Early-Stage Human Lung Cancer

2019 · Yannick Berker, Lindsey A. Vandergrift, et al. · Scientific Reports · 31

PDF

Metabolomic prostate cancer fields in HRMAS MRS‐profiled histologically benign tissue vary with cancer status and distance from cancer

2019 · Sarah S. Dinges, Lindsey A. Vandergrift, et al. · NMR in Biomedicine · 24

Treatment of Infants and Children With SARS-CoV-2 Monoclonal Antibodies: A European Case Series

2022 · Cornelius Rau, Lorenz Auer-Hackenberg, et al. · The Pediatric Infectious Disease Journal · 11

Screening Newborns for Low T Cell Receptor Excision Circles (TRECs) Fails to Detect Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome

2023 · Olga Staudacher, Jeanette Klein, et al. · The Journal of Allergy and Clinical Immunology In Practice · 4

Monogenic Inborn Errors of Immunity with impaired IgG response to polysaccharide antigens but normal IgG levels and normal IgG response to protein antigens

2024 · Maria Fasshauer, Sarah Dinges, et al. · Frontiers in Pediatrics · 3

Differentiation of patients with and without prostate cancer using urine 1H NMR metabolomics

2023 · Anna‐Laura Hasubek, Xiaoyu Wang, et al. · Magnetic Resonance in Chemistry · 2

Autosomal recessive HOXA3 deficiency causes congenital athymia and laryngeal malformation

2026 · Sarah S. Dinges, Marita Bosticardo, et al. · Journal of Allergy and Clinical Immunology

Derivation of Mesenchymal Stem Cells from Induced Pluripotent Stem Cells and Their Application in Genetic Disease Modeling 2307485

2026 · Giuseppe Sangiorgio, Francesca Pala, et al. · The Journal of Immunology

PDF

Does CVID exist in children? A genetic architecture and manifestation map derived from 7,525 patients

2026 · Antonios Gkantaras, ESID Registry Working Party, et al. · Journal of Human Immunity

Derivation of Mesenchymal Stem Cells from Induced Pluripotent Stem Cells and Their Application in Genetic Disease Modeling

2026 · Giuseppe Sangiorgio, Francesca Pala, et al. · Journal of Human Immunity

Autosomal-recessive IL-1RacP deficiency – a novel Inborn Error of Immunity supporting a non-redundant role of IL-1 signalling in Invasive Pneumococcal Disease

2026 · M Völler, A Balázs, et al. · Klinische Pädiatrie

Bronchiectasis and chronic active EBV (CAEBV) as first signs of IRF8-deficiency

2026 · M Völler, H Ham, et al. · Klinische Pädiatrie

Bronchiectasis as first sign of TlowB+NK+ combined immunodeficiency in a 7-year-old patient

2026 · S Augustin, M Mandry, et al. · Klinische Pädiatrie

Abstract 2222: Detecting clinically significant prostate cancers: Tissue metabolomics refines multiparametric MRI-ultrasound fusion prostate biopsy

2022 · Leo L. Cheng, Adam S. Feldman, et al. · Cancer Research

Mp35-03 Metabolomic Evaluation of Mri/us Fusion Biopsies Differentiates Malignant From Benign

2018 · Adam Feldman, Lindsey Vandergrift, et al. · The Journal of Urology

PDF

Works count: 19

Citation count: 312

H-index: 6

I10-index: 6